Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in Q3 2016

European Healthtech startup funding raised during Q3 2016.

In Q3 2016, 71 European Healthtech companies closed 73 funding rounds and raised €393M in equity funding (excluding debt and grants), down 45.2% versus Q3 2015. Debt rounds added €1.0M. Germany led by capital raised, and Bayern Kapital was the most active investor. Data as of 20 Nov 2026.

Equity funding
€393M
-45.2% vs Q3 2015 · excl. debt & grants · +€1.0M debt
Funding rounds
73
+19.7% vs Q3 2015
Companies
71
Top country
Germany
Rank among sectors
#4
6.9% of sector funding
Debt financing
€1.0M
0.2% of total
Top-10 round share
61.5%
of disclosed capital

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, Q3 2016 — interactive chart.
Data table
FundingRounds
Jul€181M26
Aug€34M17
Sep€182M30

Top countries

by € raised
Healthtech — top countries by capital, Q3 2016 — interactive chart.
Data table
Healthtech — top countries by capital, Q3 2016
Germany€106M
UK€83M
Ireland€37M
Switzerland€35M
Israel€30M
France€25M
Sweden€21M
Netherlands€21M

Stage mix

by € raised
Healthtech — stage mix, Q3 2016 — interactive chart.
Data table
Healthtech — stage mix, Q3 2016
Series A€162M
Growth/Late€100M
Series B€84M
Series C€21M
Early VC€19M
Seed€8.2M
Grant€2.4M
Debt€1.0M

Exits & M&A

6 Acquisition · 2 IPO

8 exits · €82M disclosed.

Creo MedicalIPOJul 2016€74M
CellinkIPOAug 2016€8.1M

Top deals

largest disclosed rounds in Q3 2016
CompanyStageDateAmount
Brillen.deGrowth/LateJul 2016€45M
IOmx TherapeuticsSeries ASep 2016€40M
SpineartGrowth/LateSep 2016€30M
ArtiosSeries ASep 2016€29M
Cambridge Medical RoboticsSeries AJul 2016€18M
Aspect ImagingGrowth/LateJul 2016€18M
NyxoahSeries BJul 2016€18M
Vivasure MedicalSeries CSep 2016€16M
InflazomeSeries ASep 2016€15M
RigontecSeries ASep 2016€14M
NightBalanceSeries BJul 2016€13M
Big HealthSeries BJul 2016€11M
LifesumSeries BJul 2016€9.1M
ImmunArraySeries BJul 2016€9.1M
EyevensysSeries ASep 2016€9.0M

Top investors

most active in Q3 2016, by deal count